Two executions carried out one week apart in the United States have ignited controversy surrounding the practice of capital punishment via lethal injection. The cases have brought renewed scrutiny to the drugs used and the protocols followed in administering them. This debate centers on whether the current methods inflict undue pain and constitute cruel and unusual punishment, violating constitutional rights. Concerns have been raised regarding the sourcing of the drugs, as pharmaceutical companies increasingly refuse to supply them for use in executions. The differing outcomes or observed circumstances surrounding the two recent executions in the United States have further fueled the ethical and legal arguments against the death penalty. Advocates are calling for greater transparency and a re-evaluation of current practices.